Development and assessment of amine-functionalized KIT-6 for In Vitro drug delivery using Juglone as the therapeutic agent
Bibliographic record
Abstract
No abstract is available for this record. The assistant can identify its topic from the title, but cannot infer the study’s results.
Source: Not provided · Quality: missing
Research context
OpenAlex topics: Mesoporous Materials and Catalysis · Clay minerals and soil interactions · Polymer Nanocomposites and Properties
SciVX discovery tags are terminology-based. OpenAlex topics are source-provided classifications.
References (60)
Show source-provided references
1. B.K. Aithal, M.R.S. Kumar, B.N. Rao, N. Udupa, B.S.S. Rao, Juglone, a naphthoquinone from walnut, exerts cytotoxic and genotoxic effects against cultured melanoma tumor cells. Cell Biol. Int. 33(10), 1039–1049 (2009)10.1016/j.cellbi.2009.06.018 ↗
2. K.D. Coder, Black walnut allelopathy: Tree chemical warfare. (2011)
3. K.-C. Lee, Nature and occurrence of juglone in Juglans nigra L. (1967)
4. I. Kocacë Aliskan, I. Terzi, Allelopathic effects of walnut leaf extracts and juglone on seed germination and seedling growth. J. Hortic. Sci. Biotechnol. 76(4), 436–440 (2001)10.1080/14620316.2001.11511390 ↗
5. M.T. Paulsen, M. Ljungman, The natural toxin juglone causes degradation of p53 and induces rapid H2AX phosphorylation and cell death in human fibroblasts. Toxicol. Appl. Pharmacol. 209(1), 1–9 (2005)10.1016/j.taap.2005.03.005 ↗
6. A.M. Hejl, K.L. Koster, Juglone disrupts root plasma membrane H+-ATPase activity and impairs water uptake, root respiration, and growth in soybean (Glycine max) and corn (Zea mays). J. Chem. Ecol. 30, 453–471 (2004)10.1023/B:JOEC.0000017988.20530.d5 ↗
7. J.J. Inbaraj, C.F. Chignell, Cytotoxic action of juglone and plumbagin: a mechanistic study using HaCaT keratinocytes. Chem. Res. Toxicol. 17(1), 55–62 (2004)10.1021/tx034132s ↗
8. H. Esterbauer, K.H. Cheeseman, [42] Determination of aldehydic lipid peroxidation products: malonaldehyde and 4-hydroxynonenal, in Methods in enzymology, vol. 186, Elsevier, 1990, pp. 407–42110.1016/0076-6879(90)86134-H ↗
9. S. Abdollahi, F. Lotfipour, PLGA-and PLA-based polymeric nanoparticles for antimicrobial drug delivery. Biomed. Int. 3(1), 1–11 (2012)
10. R. Dinarvand, nima Sepehri, S. Manoochehri, H. Rouhani, F. Atyabi, Polylactide-co-glycolide nanoparticles for controlled delivery of anticancer agents. Int. J. Nanomed. 877–895 (2011)10.2147/IJN.S18905 ↗
11. F. Esmaeili, M. Hosseini-Nasr, M. Rad-Malekshahi, N. Samadi, F. Atyabi, R. Dinarvand, Preparation and antibacterial activity evaluation of rifampicin-loaded poly lactide-co-glycolide nanoparticles. Nanomedicine 3(2), 161–167 (2007)10.1016/j.nano.2007.03.003 ↗
12. W.S. Cheow, M.W. Chang, K. Hadinoto, Antibacterial efficacy of inhalable levofloxacin-loaded polymeric nanoparticles against E. coli biofilm cells: the effect of antibiotic release profile. Pharm. Res. 27, 1597–1609 (2010)10.1007/s11095-010-0142-6 ↗
13. . Kumari, V. Kant, G.A. Chandratre, M. Ahuja, Formulation and evaluation of pluronic f-127 thermoresponsive nanogels containing juglone for In vivo wound healing potential. Bionanosci. 0123456789 (2024). https://doi.org/10.1007/s12668-024-01429-610.1007/s12668-024-01429-6 ↗
14. S. Erisen, T. Arasoǧlu, B. Mansuroglu, I. Kocacaliskan, S. Derman, Cytotoxic and mutagenic potential of juglone: a comparison of free and nano-encapsulated form. Arh. Hig. Rada Toksikol. 71(1), 69–77 (2020). https://doi.org/10.2478/aiht-2020-71-334410.2478/aiht-2020-71-3344 ↗
15. D.L. Wise, Handbook of pharmaceutical controlled release technology. CRC press, (2000)10.1201/9781482289985 ↗
16. I. Brigger, C. Dubernet, P. Couvreur, Nanoparticles in cancer therapy and diagnosis. Adv. Drug Deliv. Rev. 64, 24–36 (2012)10.1016/j.addr.2012.09.006 ↗
17. S. Chan, P.M. Fauchet, Y. Li, L.J. Rothberg, B.L. Miller, Porous silicon microcavities for biosensing applications. Phys. Status Solidi 182(1), 541–546 (2000)10.1002/1521-396X(200011)182:1<541::AID-PSSA541>3.0.CO;2-# ↗
18. K.-P.S. Dancil, D.P. Greiner, M.J. Sailor, A porous silicon optical biosensor: detection of reversible binding of IgG to a protein A-modified surface. J. Am. Chem. Soc. 121(34), 7925–7930 (1999)10.1021/ja991421n ↗
19. J.L. Coffer et al., Porous silicon-based scaffolds for tissue engineering and other biomedical applications. Phys. Status Solidi (a) 202(8), 1451–1455 (2005)10.1002/pssa.200461134 ↗
20. L.T. Canham et al., Calcium phosphate nucleation on porous silicon: factors influencing kinetics in acellular simulated body fluids. Thin Solid Films 297(1–2), 304–307 (1997)10.1016/S0040-6090(96)09534-X ↗
21. L.T. Canham, C.L. Reeves, D.O. King, P.J. Branfield, J.G. Crabb, M.C.L. Ward, Bioactive polycrystalline silicon. Adv. Mater. 8(10), 850–852 (1996)10.1002/adma.19960081020 ↗
22. L. Vaccari, D. Canton, N. Zaffaroni, R. Villa, M. Tormen, E. di Fabrizio, Porous silicon as drug carrier for controlled delivery of doxorubicin anticancer agent. Microelectron. Eng. 83(4–9), 1598–1601 (2006)10.1016/j.mee.2006.01.113 ↗
23. C. Charnay, S. Bégu, C. Tourné-Péteilh, L. Nicole, D.A. Lerner, J.-M. Devoisselle, Inclusion of ibuprofen in mesoporous templated silica: drug loading and release property. Eur. J. Pharm. Biopharm. 57(3), 533–540 (2004)10.1016/j.ejpb.2003.12.007 ↗
24. J.L. Coffer, J. Montchamp, J.B. Aimone, R.P. Weis, Routes to calcified porous silicon: implications for drug delivery and biosensing. Phys. Status Solidi (a) 197(2), 336–339 (2003)10.1002/pssa.200306520 ↗
25. M.M. Ayad, N.A. Salahuddin, A.A. El-Nasr, N.L. Torad, Amine-functionalized mesoporous silica KIT-6 as a controlled release drug delivery carrier. Microporous Mesoporous Mater. 229, 166–177 (2016)10.1016/j.micromeso.2016.04.029 ↗
26. I.I. Slowing, J.L. Vivero-Escoto, C.-W. Wu, V.S.-Y. Lin, Mesoporous silica nanoparticles as controlled release drug delivery and gene transfection carriers. Adv. Drug Deliv. Rev. 60(11), 1278–1288 (2008)10.1016/j.addr.2008.03.012 ↗
27. Q. Zhang et al., Functionalized mesoporous silica nanoparticles with mucoadhesive and sustained drug release properties for potential bladder cancer therapy. Langmuir 30(21), 6151–6161 (2014)10.1021/la500746e ↗
28. A. Popat, S.B. Hartono, F. Stahr, J. Liu, S.Z. Qiao, G.Q.M. Lu, Mesoporous silica nanoparticles for bioadsorption, enzyme immobilisation, and delivery carriers. Nanoscale 3(7), 2801–2818 (2011)10.1039/c1nr10224a ↗
29. K.K. Sharma, T. Asefa, Efficient bifunctional nanocatalysts by simple postgrafting of spatially isolated catalytic groups on mesoporous materials. Angew. Chem. Int. Ed. 46(16), 2879–2882 (2007)10.1002/anie.200604570 ↗
30. M. Vallet-Regi, A. Rámila, R.P. Del Real, J. Pérez-Pariente, A new property of MCM-41: drug delivery system. Chem. Mater. 13(2), 308–311 (2001)10.1021/cm0011559 ↗
31. M. Manzano et al., Studies on MCM-41 mesoporous silica for drug delivery: effect of particle morphology and amine functionalization. Chem. Eng. J. 137(1), 30–37 (2008)10.1016/j.cej.2007.07.078 ↗
32. D.D. Das, P.J.E. Harlick, A. Sayari, Applications of pore-expanded MCM-41 silica: 4. Synthesis of a highly active base catalyst. Catal. Commun. 8(5), 829–833 (2007)10.1016/j.catcom.2006.09.012 ↗
33. M. Selvaraj, A. Pandurangan, K.S. Seshadri, P.K. Sinha, K.B. Lal, Synthesis, characterization and catalytic application of MCM-41 mesoporous molecular sieves containing Zn and Al. Appl. Catal. A Gen. 242(2), 347–364 (2003)10.1016/S0926-860X(02)00527-6 ↗
34. Y. Gök, H. Demir, H.Z. Gök, Cationic mercaptopyridine-substituted phthalocyanine/MCM-41: an efficient photocatalyst for visible-light synthesis of juglone. J. Nanopart. Res. 27(11), 286 (2025)10.1007/s11051-025-06483-z ↗
35. A. Khanmohammadi, V. Rashidi, S. Sadighian, Reduced graphene oxide / silica nanocomposite as anticancer drug delivery nanocarrier. 13(4), (2023)10.33263/BRIAC134.383 ↗
36. B. Jaime-Escalante, A. Rolón-Ávalos, L.M. Melgoza-Contreras, G. Leyva-Gómez, M.J. Emparan-Legaspi, N. Mendoza-Muñoz, A novel strategy to produce spherical SBA-15 by polymeric macrospheres as a template for drug delivery. J. Porous Mater. 32(1), 141–153 (2025)10.1007/s10934-024-01685-7 ↗
37. F. Kleitz, S.H. Choi, R. Ryoo, Cubic Ia 3 d large mesoporous silica: synthesis and replication to platinum nanowires, carbon nanorods and carbon nanotubes. Chem. Commun. 17, 2136–2137 (2003)10.1039/b306504a ↗
38. T.-W. Kim, F. Kleitz, B. Paul, R. Ryoo, MCM-48-like large mesoporous silicas with tailored pore structure: facile synthesis domain in a ternary triblock copolymer− butanol− water system. J. Am. Chem. Soc. 127(20), 7601–7610 (2005)10.1021/ja042601m ↗
39. F. Zhang et al., Ordered mesoporous Ag–TiO 2–KIT-6 heterostructure: synthesis, characterization and photocatalysis. J. Mater. Chem. 19(18), 2771–2777 (2009)10.1039/b818495j ↗
40. T. Tsoncheva, L. Ivanova, J. Rosenholm, M. Linden, Cobalt oxide species supported on SBA-15, KIT-5 and KIT-6 mesoporous silicas for ethyl acetate total oxidation. Appl. Catal. B Environ. 89(3–4), 365–374 (2009)10.1016/j.apcatb.2008.12.015 ↗
41. K. Soni et al., 3-D ordered mesoporous KIT-6 support for effective hydrodesulfurization catalysts. Appl. Catal. B Environ. 90(1–2), 55–63 (2009)10.1016/j.apcatb.2009.02.010 ↗
42. A. Duan et al., Synthesis of hierarchically porous L-KIT-6 silica–alumina material and the super catalytic performances for hydrodesulfurization of benzothiophene. Appl. Catal. B Environ. 165, 763–773 (2015)10.1016/j.apcatb.2014.10.078 ↗
43. B. Hu, H. Liu, K. Tao, C. Xiong, S. Zhou, Highly active doped mesoporous KIT-6 catalysts for metathesis of 1-butene and ethene to propene: the influence of neighboring environment of W species. J. Phys. Chem. C 117(49), 26385–26395 (2013)10.1021/jp4098028 ↗
44. D.E. Yilmaz, Juglone encapsulation in PLGA nanoparticles improves solubility and enhances apoptosis in HeLa cells. Cell Biochem. Biophys. (2025). https://doi.org/10.1007/s12013-025-01691-910.1007/s12013-025-01691-9 ↗
45. S. Jangra, P. Girotra, V. Chhokar, V.K. Tomer, A.K. Sharma, S. Duhan, In-vitro drug release kinetics studies of mesoporous SBA-15-azathioprine composite. J. Porous Mater. 23(3), 679–688 (2016). https://doi.org/10.1007/s10934-016-0123-110.1007/s10934-016-0123-1 ↗
46. M.J. de Jesús Valle, P. Coutinho, M.P. Ribeiro, A.S. Navarro, Lyophilized tablets for focal delivery of fluconazole and itraconazole through vaginal mucosa, rational design and in vitro evaluation. Eur. J. Pharm. Sci. 122, 144–151 (2018)10.1016/j.ejps.2018.06.030 ↗
47. S. Khan, N. Anwar, Gelatin/carboxymethyl cellulose based stimuli-responsive hydrogels for controlled delivery of 5-fluorouracil, development, in vitro characterization, in vivo safety and bioavailability evaluation. Carbohydr. Polym. 257, 117617 (2021)10.1016/j.carbpol.2021.117617 ↗
48. F. Notario-Perez et al., Development of pH-sensitive vaginal films based on methacrylate copolymers for topical HIV-1 pre-exposure prophylaxis. Acta Biomater. 121, 316–327 (2021)10.1016/j.actbio.2020.12.019 ↗
49. F. Tuğcu-Demiröz, S. Saar, A.A. Kara, A. Yıldız, E. Tunçel, F. Acartürk, Development and characterization of chitosan nanoparticles loaded nanofiber hybrid system for vaginal controlled release of benzydamine. Eur. J. Pharm. Sci. 161, 105801 (2021)10.1016/j.ejps.2021.105801 ↗
50. T. Mosmann, Rapid colorimetric assay for cellular growth and survival: application to proliferation and cytotoxicity assays. J. Immunol. Methods 65(1–2), 55–63 (1983)10.1016/0022-1759(83)90303-4 ↗
51. S. Kachbouri, N. Mnasri, E. Elaloui, Y. Moussaoui, Tuning particle morphology of mesoporous silica nanoparticles for adsorption of dyes from aqueous solution. J. Saudi Chem. Soc. 22(4), 405–415 (2018)10.1016/j.jscs.2017.08.005 ↗
52. C. Li et al., A novel method to extract juglone from Juglans mandshurica waste branches using a water-in-oil microemulsion. Waste Biomass Valoriz. (2022). https://doi.org/10.1007/s12649-021-01611-x10.1007/s12649-021-01611-x ↗
53. I. Ebrahimi, M. Parvinzadeh Gashti, Extraction of polyphenolic dyes from henna, pomegranate rind, and Pterocarya fraxinifolia for nylon 6 dyeing. Coloration Technol. 132(2), 162–176 (2016)10.1111/cote.12204 ↗
54. A.M. Donia, A.A. Atia, W.A. Al-Amrani, A.M. El-Nahas, Effect of structural properties of acid dyes on their adsorption behaviour from aqueous solutions by amine modified silica. J. Hazard. Mater. 161(2–3), 1544–1550 (2009)10.1016/j.jhazmat.2008.05.042 ↗
55. H. Yang, Q. Feng, Direct synthesis of pore-expanded amino-functionalized mesoporous silicas with dimethyldecylamine and the effect of expander dosage on their characterization and decolorization of sulphonated azo dyes. Microporous Mesoporous Mater. 135(1–3), 124–130 (2010)10.1016/j.micromeso.2010.06.019 ↗
56. M. Anbia, S. Amirmahmoodi, Adsorption of phenolic compounds from aqueous solutions using functionalized SBA-15 as a nano-sorbent. Sci. Iran. 18(3), 446–452 (2011)10.1016/j.scient.2011.05.007 ↗
57. K. Möller, T. Bein, Talented mesoporous silica nanoparticles. Chem. Mater. 29(1), 371–388 (2017)10.1021/acs.chemmater.6b03629 ↗
58. J.C. Doadrio, E.M.B. Sousa, I. Izquierdo-Barba, A.L. Doadrio, J. Perez-Pariente, M. Vallet-Regí, Functionalization of mesoporous materials with long alkyl chains as a strategy for controlling drug delivery pattern. J. Mater. Chem. 16(5), 462–466 (2006)10.1039/B510101H ↗
59. P. Kumari, V. Kant, G.A. Chandratre, M. Ahuja, Formulation and evaluation of pluronic F-127 thermoresponsive nanogels containing juglone for in vivo wound healing potential. Bionanoscience (2024). https://doi.org/10.1007/s12668-024-01429-610.1007/s12668-024-01429-6 ↗
60. M.L. Bruschi, Strategies to modify the drug release from pharmaceutical systems. Woodhead Publishing, 2015